Skip to main content

Janux Therapeutics, Inc.

JANX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001817713

No open-market purchases or sales by Janux Therapeutics, Inc. insiders were filed in the last 90 days; 197 institutions reported holding it in 13F filings for Q2 2026, worth $933.4M in total; no superinvestor holds it.

13F holders, Q1 2025

Institutional positions in Janux Therapeutics, Inc. as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
181
−34 vs. Q4 2024
Shares held
66.5M
+2.47M (+3.9%) vs. Q4 2024
Total value
$1.81B
−$1.62B (−47.3%) vs. Q4 2024
New holders
19
96 more added
Sold out
53
44 more reduced

1 institution that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q4 2024: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting JANX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ1 2025: 181 institutions
Q1 2021: 0 institutionsQ2 2021: 30 institutionsQ3 2021: 45 institutionsQ4 2021: 46 institutionsQ1 2022: 47 institutionsQ2 2022: 44 institutionsQ3 2022: 49 institutionsQ4 2022: 50 institutionsQ1 2023: 48 institutionsQ2 2023: 54 institutionsQ3 2023: 57 institutionsQ4 2023: 64 institutionsQ1 2024: 121 institutionsQ2 2024: 155 institutionsQ3 2024: 160 institutionsQ4 2024: 216 institutionsQ1 2025: 181 institutionsQ2 2025: 174 institutionsQ3 2025: 174 institutionsQ4 2025: 176 institutionsQ1 2026: 190 institutionsQ2 2026: 197 institutions
Value heldQ1 2025: $1.81B
Q1 2021: $0Q2 2021: $614.5MQ3 2021: $571.2MQ4 2021: $541.6MQ1 2022: $407.1MQ2 2022: $353.0MQ3 2022: $400.3MQ4 2022: $381.3MQ1 2023: $369.5MQ2 2023: $362.1MQ3 2023: $354.0MQ4 2023: $359.5MQ1 2024: $1.59BQ2 2024: $1.87BQ3 2024: $2.07BQ4 2024: $3.43BQ1 2025: $1.81BQ2 2025: $1.51BQ3 2025: $1.59BQ4 2025: $860.0MQ1 2026: $827.8MQ2 2026: $933.4M
Institutions holding JANX and their total value by quarter
QuarterHoldersValue
Q2 2026197$933.4M
Q1 2026190$827.8M
Q4 2025176$860.0M
Q3 2025174$1.59B
Q2 2025174$1.51B
Q1 2025181$1.81B
Q4 2024216$3.43B
Q3 2024160$2.07B
Q2 2024155$1.87B
Q1 2024121$1.59B
Q4 202364$359.5M
Q3 202357$354.0M
Q2 202354$362.1M
Q1 202348$369.5M
Q4 202250$381.3M
Q3 202249$400.3M
Q2 202244$353.0M
Q1 202247$407.1M
Q4 202146$541.6M
Q3 202145$571.2M
Q2 202130$614.5M
Q1 20210$0

Institutions, Q1 2025

Shares, value and share of portfolio for each institution holding Janux Therapeutics, Inc.; share changes are against Q4 2024.

Institutions holding JANX in Q1 2025
InstitutionSharesValue% of portfolioChange in sharesAction
Teachers Retirement System of the State of Kentucky0$00.00%−12,200−100.0%Sold out
Samsara BioCapital, LLC0$00.00%−11,263−100.0%Sold out
Prelude Capital Management, LLC0$00.00%−10,231−100.0%Sold out
SEI Investments Co0$00.00%−9,378−100.0%Sold out
Virtu Financial LLC0$00.00%−8,769−100.0%Sold out
Allianz Asset Management GmbH0$00.00%−8,400−100.0%Sold out
Bayesian Capital Management, LP0$00.00%−8,300−100.0%Sold out
LPL Financial LLC0$00.00%−8,202−100.0%Sold out
Shay Capital LLC0$00.00%−7,000−100.0%Sold out
Freestone Grove Partners LP0$00.00%−6,807−100.0%Sold out
Bailard, Inc.0$00.00%−6,500−100.0%Sold out
Legato Capital Management LLC0$00.00%−6,479−100.0%Sold out
Bamco Inc0$00.00%−6,000−100.0%Sold out
Verition Fund Management LLC0$00.00%−5,618−100.0%Sold out
Brinker Capital Investments, LLC0$00.00%−4,913−100.0%Sold out
Orion Portfolio Solutions, LLC0$00.00%−4,913−100.0%Sold out
STRS Ohio0$00.00%−4,600−100.0%Sold out
Cerity Partners LLC0$00.00%−4,478−100.0%Sold out
Chicago Partners Investment Group LLC0$00.00%−4,621−100.0%Sold out
Chicago Capital, LLC0$00.00%−4,300−100.0%Sold out
Brevan Howard Capital Management LP0$00.00%−4,137−100.0%Sold out
Westfield Capital Management Co LP0$00.00%−3,910−100.0%Sold out
Jane Street Group, LLC0$00.00%−3,814−100.0%Sold out
Meeder Asset Management Inc0$00.00%−2,972−100.0%Sold out
Virtus ETF Advisers LLC0$00.00%−1,156−100.0%Sold out
Plato Investment Management Ltd0$00.00%−498−100.0%Sold out
Measured Risk Portfolios, Inc.0$00.00%−400−100.0%Sold out
Nelson, Van Denburg & Campbell Wealth Management Group, LLC0$00.00%−98−100.0%Sold out
LRI Investments, LLC0$00.00%−92−100.0%Sold out
Point72 Asia (Singapore) Pte. Ltd.0$00.00%−70−100.0%Sold out
Creative Planning0$00.00%−65−100.0%Sold out
R Squared Ltd0$00.00%−20−100.0%Sold out
CoreCap Advisors, LLC0$00.00%−9−100.0%Sold out
Quantbot Technologies LP0$00.00%−1−100.0%Sold out
Nuveen Asset Management, LLC––––Not filed